Professor Dame Margaret Brimble CChem F欧美AV
Winner: 2022 Organic Division open award:
Pedler Award
The University of Auckland
For a large body of pioneering work spanning the fields of natural product synthesis, peptide chemistry, and medicinal chemistry.
Celebrate Professor Dame Margaret Brimble
#欧美AVPrizes
I am excited that a molecule we made over 20 years ago is getting over the last hurdle to become the first FDA approved drug to treat Rett syndrome….
Natural products have long been regarded as ‘nature’s medicine chest’, providing invaluable platforms for developing frontline drugs. Over 50% of all new drugs approved by the US Food and Drug Administration (FDA) are ‘inspired’ by natural products. Dame Margaret’s research focuses on the synthesis of novel bioactive natural products (especially molecules derived from extreme environments and shellfish toxins) as novel anticancer, antibacterial and antiviral agents. She also works on the synthesis of antimicrobial peptides as potential new antibiotics and peptidomimetics as antiviral agents.
Dame Margaret’s team discovered the drug candidate NNZ2566 (named trofinetide by the World Health Organisation). It proved successful in phase 3 clinical trials (pending FDA approval in 2022) with Neuren Pharmaceuticals and Acadia Pharmaceuticals for the neurogenic disorder Rett Syndrome.
Read winner biography